<bill session="108" type="h" number="2931" updated="2023-01-15T06:02:46Z">
  <state datetime="2003-07-25">REFERRED</state>
  <status>
    <introduced datetime="2003-07-25"/>
  </status>
  <introduced datetime="2003-07-25"/>
  <titles>
    <title type="display">Orphan Drug Tax Credit Act of 2003</title>
    <title type="official" as="introduced">To provide for the expansion of human clinical trials qualifying for the orphan drug credit.</title>
    <title type="short" as="introduced">Orphan Drug Tax Credit Act of 2003</title>
  </titles>
  <sponsor bioguide_id="B000755"/>
  <cosponsors>
    <cosponsor bioguide_id="M000249" joined="2003-07-25"/>
  </cosponsors>
  <actions>
    <action datetime="2003-07-25">
      <text>Introduced in House</text>
    </action>
    <action datetime="2003-07-25" state="REFERRED">
      <text>Referred to the House Committee on Ways and Means.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Taxation"/>
    <term name="Clinical trials"/>
    <term name="Commerce"/>
    <term name="Drug industry"/>
    <term name="Health"/>
    <term name="Income tax"/>
    <term name="Orphan drugs"/>
    <term name="Pharmaceutical research"/>
    <term name="Research and development tax credit"/>
    <term name="Science, Technology, Communications"/>
  </subjects>
  <amendments/>
  <summary date="2003-08-26T14:09:59Z" status="Introduced in House">Orphan Drug Tax Credit Act of 2003 - Amends the Internal Revenue Code to move up the date for which a taxpayer may claim the credit for the clinical testing of drugs for rare diseases or conditions (orphan drugs) from the date a drug is designated an orphan drug to the date the application for such designation is filed.</summary>
</bill>
